Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Liting Lu

2PUBLICATIONS
9CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Jun 24, 2023
PDE4DIP contributes to colorectal cancer growth and chemoresistance through modulation of the NF1/RAS signaling axis.

Rulu Pan, Juji Dai, Weicheng Liang

|Sep 30, 2021
Epigenetic induction of lipocalin 2 expression drives acquired resistance to 5-fluorouracil in colorectal cancer through integrin β3/SRC pathway.

Wenyi Zhang, Rulu Pan, Mei Lu

Pageof 1

Frequent Collaborators

2 joint publications

Ziqi Lin

2 joint publications

Wanqin Liao

2 joint publications

Xincheng Lu

1 joint publications

Wenyi Zhang

1 joint publications

Mei Lu

1 joint publications

Qian Zhang

1 joint publications

Yuan Qin

1 joint publications

Zhanyu Wang

1 joint publications

Siqing Gong

Frequent Collaborators

2 joint publications

Ziqi Lin

2 joint publications

Wanqin Liao

2 joint publications

Xincheng Lu

1 joint publications

Wenyi Zhang

Top Related Videos

Identification of EGFR and RAS Inhibitors using <em>Caenorhabditis elegans</em>
08:12

Identification of EGFR and RAS Inhibitors using <em>Caenorhabditis elegans</em>

Published on : Oct 05, 2020

3.1K
Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on : Sep 30, 2016

14.0K
See more related videos

Top Related Videos

Identification of EGFR and RAS Inhibitors using <em>Caenorhabditis elegans</em>
08:12

Identification of EGFR and RAS Inhibitors using <em>Caenorhabditis elegans</em>

Published on : Oct 05, 2020

3.1K
Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on : Sep 30, 2016

14.0K
See more related videos